|
|
Food | |
|
High-potassium foods* Pleurisy root* Potassium | |
| Depletion or interference |
None known |
| Side effect reduction/prevention |
None known |
| Reduced drug absorption/bioavailability |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Potassium
Three kidney transplant patients developed hyperkalemia (high blood potassium levels), a
potentially dangerous condition, following intravenous administration of
labetalol.1 Additional research is needed to determine whether taking oral
labetalol together with potassium supplements might also lead to elevated blood levels of
potassium. However, some other beta-blockers (called “nonselective” beta-blockers)
are known to decrease the uptake of potassium from the blood into the cells,2
leading to hyperkalemia.3 People taking beta-blockers should therefore avoid taking
potassium supplements, or eating large quantities of
fruit (e.g., bananas), unless directed to do so by
their doctor.
Pleurisy root
As pleurisy root and other plants in the Aesclepius genus contain cardiac glycosides,
it is best to avoid use of pleurisy root with heart medications such as
beta-blockers.4
Food
Taking labetalol with food greatly increases the absorption of the drug.5
Therefore, labetalol should be taken with a meal.
1. Arthur S, Greenberg A. Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients. Clin Nephrol 1990;33:269–71.
2. Rosa RM, Silva P, Young JB, et al. Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 1980;302:431–4.
3. Lundborg P. The effect of adrenergic blockade on potassium concentrations in different conditions. Acta Med Scand Suppl 1983;672:121–6 [review].
4. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: Pharmaceutical Press, 1996, 213–4.
5. Daneshmend TK, Roberts CJ. the influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol. Br J Clin Pharmacol 1982;14:73–8.
| |||||||